These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8468556)

  • 41. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.
    Morrison HG; Kirchhoff F; Desrosiers RC
    Virology; 1993 Jul; 195(1):167-74. PubMed ID: 8317093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atomic force microscopy investigation of wild-type Moloney murine leukemia virus particles and virus particles lacking the envelope protein.
    Kuznetsov YG; Low A; Fan H; McPherson A
    Virology; 2004 Jun; 323(2):189-96. PubMed ID: 15193915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Large-scale purification of gp70 from Moloney murine leukemia virus.
    Pyle SW; Chabot DJ; Miller TL; Serabyn SA; Bess JW; Arthur LO
    J Virol Methods; 1991 May; 32(2-3):303-15. PubMed ID: 1874922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein.
    Kubo Y; Amanuma H
    J Gen Virol; 2003 Aug; 84(Pt 8):2253-2257. PubMed ID: 12867658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of cell cytoskeleton in Mo-MuLV env transport and processing: implications in ts1 neuropathology.
    Soong MM; Tompkins WA
    Exp Mol Pathol; 1987 Jun; 46(3):294-311. PubMed ID: 2439368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine tumor.
    Grohmann U; Puccetti P; Belladonna ML; Fallarino F; Bianchi R; Binaglia L; Sagakuchi K; Mage MG; Appella E; Fioretti MC
    J Immunol; 1995 May; 154(9):4630-41. PubMed ID: 7722315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deposition of retrovirus associated antigens (p30 and gp70) on cell membranes of feline and murine leukaemia virus infected cells.
    O'Brien SJ; Simonson JM; Davis S
    J Gen Virol; 1978 Mar; 38(3):483-96. PubMed ID: 75945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of cysteine mutations on the transmembrane protein of Moloney murine leukemia virus.
    Thomas A; Roth MJ
    Virology; 1995 Aug; 211(1):285-9. PubMed ID: 7645222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell fusion induced by the murine leukemia virus envelope glycoprotein.
    Jones JS; Risser R
    J Virol; 1993 Jan; 67(1):67-74. PubMed ID: 8416389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus.
    Erlwein O; Buchholz CJ; Schnierle BS
    J Gen Virol; 2003 Feb; 84(Pt 2):369-373. PubMed ID: 12560569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.
    Rein A; Yang C; Haynes JA; Mirro J; Compans RW
    J Virol; 1998 Apr; 72(4):3432-5. PubMed ID: 9525676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of point mutations in the envelope gene of Moloney murine leukemia virus TB temperature-sensitive paralytogenic mutant ts1: molecular determinants for neurovirulence.
    Szurek PF; Yuen PH; Jerzy R; Wong PK
    J Virol; 1988 Jan; 62(1):357-60. PubMed ID: 3334748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Murine leukemia virus transmembrane protein R-peptide is found in small virus core-like complexes in cells.
    Andersen KB; Diep HA; Zedeler A
    J Gen Virol; 2006 Jun; 87(Pt 6):1583-1588. PubMed ID: 16690922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection.
    Crawford S; Goff SP
    J Virol; 1984 Mar; 49(3):909-17. PubMed ID: 6608006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutagenesis analysis of the murine leukemia virus matrix protein: identification of regions important for membrane localization and intracellular transport.
    Soneoka Y; Kingsman SM; Kingsman AJ
    J Virol; 1997 Jul; 71(7):5549-59. PubMed ID: 9188629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus.
    Li X; McDermott B; Yuan B; Goff SP
    J Virol; 1996 Feb; 70(2):1266-70. PubMed ID: 8551593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein.
    Auerbach MR; Brown KR; Singh IR
    J Virol; 2007 Nov; 81(22):12337-47. PubMed ID: 17855544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein.
    Méric C; Goff SP
    J Virol; 1989 Apr; 63(4):1558-68. PubMed ID: 2926863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity.
    Katoh I; Yoshinaka Y; Rein A; Shibuya M; Odaka T; Oroszlan S
    Virology; 1985 Sep; 145(2):280-92. PubMed ID: 2411050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a conformationally sensitive epitope on Moloney murine leukemia virus gp70.
    Trauger R; Rayfield MA; Luftig RB
    Intervirology; 1987; 28(1):40-9. PubMed ID: 2448265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.